Insider Transactions in Q2 2025 at Corvus Pharmaceuticals, Inc. (CRVS)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 27
2025
|
Orbimed Advisors LLC Director |
SELL
Open market or private sale
|
Indirect |
1,176,332
-14.1%
|
$4,705,328
$4.16 P/Share
|
|
Jun 27
2025
|
Orbimed Advisors LLC Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,397,684
+14.35%
|
$4,193,052
$3.5 P/Share
|
|
Jun 27
2025
|
Peter A. Thompson Director |
SELL
Open market or private sale
|
Indirect |
1,176,332
-14.1%
|
$4,705,328
$4.16 P/Share
|
|
Jun 27
2025
|
Peter A. Thompson Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,397,684
+14.35%
|
$4,193,052
$3.5 P/Share
|
|
Jun 04
2025
|
William Benton Jones |
BUY
Exercise of conversion of derivative security
|
Direct |
19,357
+10.06%
|
$58,071
$3.5 P/Share
|
|
May 07
2025
|
Richard A Md Miller President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
559,073
+32.97%
|
$1,677,219
$3.5 P/Share
|